Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
UBS
McKinsey
Baxter
Express Scripts
Daiichi Sankyo
US Department of Justice
Fuji
Federal Trade Commission
AstraZeneca

Generated: October 20, 2017

DrugPatentWatch Database Preview

ACETAMINOPHEN; CODEINE PHOSPHATE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for acetaminophen; codeine phosphate and what is the scope of acetaminophen; codeine phosphate patent protection?

Acetaminophen; codeine phosphate
is the generic ingredient in seventeen branded drugs marketed by Aurolife Pharma Llc, Vintage, Wockhardt, Warner Chilcott, Whiteworth Town Plsn, Pharm Assoc, Roxane, Vangard, Everylife, Sandoz, Hi Tech Pharma, Mallinckrodt Inc, Usl Pharma, Ortho Mcneil Pharm, Duramed Pharms Barr, Teva, Valeant Pharms Llc, Vintage Pharms, Mikart, Lederle, Watson Labs Florida, Carnrick, Robins Ah, Halsey, Glaxosmithkline, Able, Mutual Pharm, Superpharm, Janssen Pharms, Actavis Mid Atlantic, Puracap Pharm, Kv Pharm, Allied Pharma Inc, Sun Pharm Inds Ltd, Anda Repository, Watson Labs, Vitarine, Am Therap, Amneal Pharms Ny, Purepac Pharm, Solvay, Valeant Pharm Intl, and Dava Pharms Inc, and is included in one hundred and ten NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-six drug master file entries for acetaminophen; codeine phosphate. Fifty-seven suppliers are listed for this compound.

Summary for Generic Name: ACETAMINOPHEN; CODEINE PHOSPHATE

US Patents:0
Tradenames:17
Applicants:43
NDAs:110
Drug Master File Entries: see list66
Suppliers / Packagers: see list57
Bulk Api Vendors: see list1
Clinical Trials: see list1,549
Patent Applications: see list99
Drug Prices:see low prices
DailyMed Link:ACETAMINOPHEN; CODEINE PHOSPHATE at DailyMed

Pharmacology for Ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL089997-001Dec 28, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL085218-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
CAPITAL AND CODEINE
acetaminophen; codeine phosphate
SUSPENSION;ORAL085883-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Florida
CODRIX
acetaminophen; codeine phosphate
TABLET;ORAL040488-001Mar 28, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Florida
CODRIX
acetaminophen; codeine phosphate
TABLET;ORAL040447-001Feb 26, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL087277-001May 26, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Am Therap
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL089479-001Mar 3, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL089998-001Dec 28, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Kv Pharm
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL085288-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Halsey
ACETAMINOPHEN AND CODEINE PHOSPHATE
acetaminophen; codeine phosphate
TABLET;ORAL083871-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
QuintilesIMS
Colorcon
Boehringer Ingelheim
Queensland Health
Express Scripts
Daiichi Sankyo
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot